University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan

Public research footprint of University of Michigan Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

766

Registered studies

112

Active

Recruiting now

523

Completed

112

Stopped or withdrawn

Most-studied conditions

Follicular Lymphoma · Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC… · Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck · Stage III Lip and Oral Cavity Cancer AJCC v8

Recently updated registry entries

NCT04221438 — Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph… (Terminated)
NCT05168163 — Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of… (Recruiting)
NCT04623541 — Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Michigan Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.